Skip to main content
SpringerLink
Log in

Exkurs: Affektive Störungen bei Morbus Parkinson

  • Chapter
Neuro-Psychopharmaka Ein Therapie-Handbuch

  • 86 Accesses

Zusammenfassung

Parkinsonpatienten leiden häufig unter affektiven Störungen, vor allem unter Depression und Angst (Schiffer et al. 1988, Stein et al. 1990). Die in der Literatur beschriebenen Prävalenzraten für das Vorliegen einer Depression bei der Parkinsonkrankheit reichen von vier bis 90% bei einer mittleren Häufigkeit von etwa 40–50% (Levin et al. 1988, Cummings 1992). Depressive Parkinsonpatienten haben einen verminderten Antrieb, sind wegen ihrer Gesundheit besorgt, äußern somatische Beschwerden, sind pessimistisch und betrachten ihre Lage oft als aussichtslos. Suizidgedanken kommen bei Parkinsonkranken vor, Suizide sind jedoch selten. Depression wird zuweilen bereits vor der Parkinsondiagnose beobachtet, tritt häufig etwa zum Zeitpunkt der Diagnosestellung auf und erscheint bei einer Reihe von Parkinsonpatienten erst im weiteren Verlauf der Krankheit.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Alexander GE, De Long MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9: 357–381

    Article  PubMed  CAS  Google Scholar 

  • Azmitia EC, Gannon P (1985) The serotonergic system: a review of human and animal studies and a report on Macaca fascicularis. In: Fahn S (ed) Myoclonus. Raven Press, New York

    Google Scholar 

  • Baxter LR, Schwartz JM, Phelps ME et al. (1989) Reduction of pre-frontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46: 243–250

    Article  PubMed  CAS  Google Scholar 

  • Becker G, Struck M, Bogdahn U, Becker T (1994) Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Res Neuroimaging 55: 75–84

    Article  CAS  Google Scholar 

  • Becker G, Becker T, Struck M, Lindner A, Burzer K, Retz W, Bogdahn U, Beckmann H (1995) Reduced echogenicity of brainstem raphe specific to unipolar depression: a transcranial color-coded real-time sonography study. Biol Psychiatry 38: 180–184

    Article  PubMed  CAS  Google Scholar 

  • Becker T, Becker G, Seufert J, Hofmann E, Lange KW, Naumann M, Lindner A, Reichmann H, Riederer P, Beckmann H, Reiners K (1997) Parkinson’s disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry 63: 590–596

    Article  PubMed  CAS  Google Scholar 

  • Bench CJ, Friston KJ, Brown RG et al. (1992) The anatomy of melancholia — focal abnormalities of cerebral blood flow in major depression and the cognitive impairment of depression. Psychol Med 22: 607–615

    Article  PubMed  CAS  Google Scholar 

  • Cantello R, Gilli M, Riccio A, Bergamasco B (1986) Mood changes associated with „end-of-dose deterioration“ in Parkinson’s disease: a controlled study. J Neurol Neurosurg Psychiatry 49: 1182–1192

    Article  PubMed  CAS  Google Scholar 

  • Cantello R, Aguggia M, Gilli M et al. (1989) Major depression in Parkinson’s disease and the mood response to intravenous methyphenidate: possible role of the „hedonic“ dopamine system. J Neurol Neurosurg Psychiatry 52: 724–731

    Article  PubMed  CAS  Google Scholar 

  • Celesia GG, Wanamaker WM (1972) Psychiatric disturbances in Parkinson’s disease. Dis Nerv Syst 33: 577–583

    PubMed  CAS  Google Scholar 

  • Chan-Palay V, Asan E (1989) Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson’s disease with and without dementia and depression. J Comp Neurol 287: 373–392

    Article  PubMed  CAS  Google Scholar 

  • Cummings JL (1992) Depression and Parkinson’s disease: a review. Am J Psychiatry 149: 443–457

    PubMed  CAS  Google Scholar 

  • Ehmann TS, Beninger RJ, Gawel MJ, Riopelle RJ (1990) Depressive symptoms in Parkinson’s disease: a comparison with disabled control subjects. J Geriatr Psychiatry Neurol 2: 3–9

    Article  Google Scholar 

  • Garver DL, Davis JM (1979) Biogenic amine hypothesis of affective disorders. Life Sci 24: 383–394

    Article  PubMed  CAS  Google Scholar 

  • Gotham A-M, Brown RG, Marsden CD (1986) Depression in Parkinson’s disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 49: 381–389

    Article  PubMed  CAS  Google Scholar 

  • Hoehn M, Crowley TJ, Rutledge CO (1976) Dopamine correlates of neurological and psychological status in untreated parkinsonism. J Neurol Neurosurg Psychiatry 39: 941–951

    Article  PubMed  CAS  Google Scholar 

  • Horn S (1960) Some psychological factors in parkinsonism. J Neurol Neurosurg Psychiatry 23: 56–61

    Article  Google Scholar 

  • Huber SJ, Paulson GW, Shuttleworth EC (1988) Relationship of motor symptoms, intellectual impairment, and depression in Parkinson’s disease. J Neurol Neurosurg Psychiatry 51: 855–858

    Article  PubMed  CAS  Google Scholar 

  • Jellinger K (1986) Overview of morphological changes in Parkinson’s disease. In: Yahr MD, Bergmann KJ (eds) Advances in neurology: Parkinson’s disease. Raven Press, New York, pp 1–19

    Google Scholar 

  • Kearney TR (1964) Parkinson’s disease presenting as a depressive illness. J Irish Med Assoc 54: 117–119

    CAS  Google Scholar 

  • Kostic VS, Djuricic BM, Covickovic-Sternis N et al. (1987) Depression and Parkinson’s disease: possible role of serotonergic mechnisms. J Neurol 234: 94–96

    Article  PubMed  CAS  Google Scholar 

  • Laplane D, Levasseur M, Pillon B et al. (1989) Obsessive-compulsive and other behavioral changes with bilateral basal ganglia lesions. Brain 112: 699–725

    Article  PubMed  Google Scholar 

  • Levin BE, Llabre MM, Weiner WJ (1988) Parkinson’s disease and depression: psychomeric properties of the Beck Depression Inventory. J Neurol Neurosurg Psychiatry 51: 140–144

    Google Scholar 

  • Lloyd KJ, Farley IJ, Deck JHN, Hornykiewicz O (1974) Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brainstem of suicide victims and control patients. Adv Bio-chem Psychopharmacol 11: 387–397

    CAS  Google Scholar 

  • Loranger AW, Goodel H, Lee JE et al. (1972) Intellectual impairment in Parkinson’s syndrom. Brain 95: 405–412

    Article  PubMed  CAS  Google Scholar 

  • Marsh GG, Markham CH (1973) Does levodopa alter depression and psychopathology in parkinsonism patient? J Neurol Neurosurg Psychiatry 36: 925–935

    Article  PubMed  CAS  Google Scholar 

  • Mayberg HS, Starkstein SE, Sadzot B, Preziosi T, Andrczejewski PL, Dannals RF, Wagner HN, Robinson RG (1990) Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson’s disease. Ann Neurol 26: 57–64

    Article  Google Scholar 

  • Mayeux R, Stern Y, Rosen J, Leventhal J (1981) Depression, intellectual impairment, and Parkinson’s disease. Neurology 31: 645–650

    Article  PubMed  CAS  Google Scholar 

  • Mayeux R, Stern Y, Coté L, Williams JBW (1984) Altered serotonin metabolism in depressed patients with Parkinson’s disease. Neurology 34: 642–646

    Article  PubMed  CAS  Google Scholar 

  • Mayeux, R, Stern Y, Sano M et al. (1988) The relationship of serotonin to depression in Parkinson’s disease. Mov Disord 3: 237–244

    Article  PubMed  CAS  Google Scholar 

  • Menza MA, Forman NE, Goldstein HS et al. (1990) Parkinson’s disease, personality, and dopamine. J Neuropsychiatry Clin Neurosci 2: 282–287

    PubMed  CAS  Google Scholar 

  • Menza M, Sage J, Marshall E, Cody R, Duvoisin R (1990) Mood changes and „on-off“ phenomena in Parkinson’s disease. Mov Disord 5: 148–151

    Article  PubMed  CAS  Google Scholar 

  • Menza MA, Robertson-Hoffmann DE, Bonapace AS (1993) Parkinson’s disease and anxiety: comorbidity with depression. Biol Psychiatry 34: 465–470

    Article  PubMed  CAS  Google Scholar 

  • Mindham RHS (1970) Psychiatric symptoms in parkinsonism. J Neurol Neurosurg Psychiatry 33: 188–191

    Article  PubMed  CAS  Google Scholar 

  • Mindham RHS, Marsden CD, Parkes JD (1976) Psychiatric symptoms during L-dopa therapy for Parkinson’s disease and their relationship to physical disability. Psychol Med 6: 23–33

    Article  PubMed  CAS  Google Scholar 

  • Patrick HT, Levy DM (1922) Parkinson’s disease. A clinical study of 148 cases. Arch Neurol 7: 711–720

    Google Scholar 

  • Paulus W, Jellinger K (1991) The neuropathologic basis of different clinical subgroups of Parkinson’s disease. J Neuropathol Exp Neurol 50: 743–755

    Article  PubMed  CAS  Google Scholar 

  • Raisman R, Cash R, Agid Y (1986) Parkinson’s disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen. Neurology 36: 556–560

    Article  PubMed  CAS  Google Scholar 

  • Ring HA, Bench CJ, Trimble MR, Brooks DJ, Frackowiak RSJ, Dolan RJ (1994) Depression in Parkinson’s disease. A positron emission study. Br J Psychiatry 165: 333–339

    CAS  Google Scholar 

  • Robins AH (1976) Depression in patients with Parkinson’s disease. Br J Psychiatry 128: 141–145

    Article  PubMed  CAS  Google Scholar 

  • Sano M, Stanley M, Lawton L et al. (1990) 3H-Imipramine binding as a peripheral measure of serotonin in Parkinson’s disease. Neurology 40: 425

    Google Scholar 

  • Santamaria J, Tolosa E, Valles A (1986) A Parkinson’s disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 36: 1130–1133

    Article  PubMed  CAS  Google Scholar 

  • Schiffer RB, Kurlan R, Rubin A, Boer S (1988) Evidence for atypical depression in Parkinson’s disease. Am J Psychiatry 145: 1020–1022

    PubMed  CAS  Google Scholar 

  • Schildkraut JJ (1973) Neuropharmacology of the affective disorders. Ann Rev Pharmacol 13: 427–454

    Article  PubMed  CAS  Google Scholar 

  • Stanley M, Virgilio J, Gershon S (1982) Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 216: 1337–1339

    Article  PubMed  CAS  Google Scholar 

  • Stanley M, Traskman-Bendz L, Dorovini-Zis K (1985) Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. Life Sci 37: 1279–1286

    Article  PubMed  CAS  Google Scholar 

  • Stein MB, Heuser IJ, Juncos JL, Uhde TE (1990) Anxiety disorders and Parkinson’s disease. Am J Psychiatry 147: 217–220

    PubMed  CAS  Google Scholar 

  • Taylor AE, Saint-Cyr JA, Lang AE (1988) Idiopathic Parkinson’s disease: revised concepts of cognitive and affective status. Can J Neurol Sci 15: 106–113

    PubMed  CAS  Google Scholar 

  • Van PRAAG HM (1982) Depression. Lancet ii: 1259–1264

    Google Scholar 

  • Van Praag HM, De Haan S (1979) Central serotonin metabolism and frequency of depression. Psychiatr Res 1: 219–224

    Article  Google Scholar 

  • Warburton JW (1967) Depressive symptons in Parkinson patients referred for thalamotomy. J Neurol Neurosurg Psychiatry 30: 368–370

    Article  PubMed  CAS  Google Scholar 

  • Zweig RM, Jankel WR, Hedreen JC, Mayeux R (1989) The pedunculopontine nucleus in Parkinson’s disease. Ann Neurol 26: 41–46

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. K. W. Lange
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinische Neurochemie, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Würzburg, Bundesrepublik Deutschland

    Peter Riederer

  2. Bezirkskrankenhaus Gabersee, Wasserburg/Inn, Bundesrepublik Deutschland

    Gerd Laux

  3. Wien, Österreich

    Walter Pöldinger

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Wien

About this chapter

Cite this chapter

Lange, K.W., Becker, G., Becker, T. (1999). Exkurs: Affektive Störungen bei Morbus Parkinson. In: Riederer, P., Laux, G., Pöldinger, W. (eds) Neuro-Psychopharmaka Ein Therapie-Handbuch. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6400-6_37

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6400-6_37

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7315-2

  • Online ISBN: 978-3-7091-6400-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation